Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Pharmaceutical Preparations

Standard Industrial Classification: SIC 2834

Industry Insider Sentiment Analysis

The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2026-11-20 21:10 2026-11-17 LEGN Legend Biotech Corp Zhang Ingrid Officer BUY $8.16 20,000 $163,200 1,151,860
2026-11-21 01:59 2026-11-18 BOLD Boundless Bio, Inc. TANG KEVIN 10% owner BUY $2.36 103,612 $244,234 3,152,991
2026-11-21 00:00 2026-11-18 SLS SELLAS Life Sciences Group, Inc. Stergiou Angelos M. Director, Officer SELL $19.18 26,606 $510,250 1,734,896
2026-11-21 00:00 2026-11-18 SLS SELLAS Life Sciences Group, Inc. CICIC DRAGAN Officer SELL $19.18 6,933 $132,961 557,361
2026-11-21 00:01 2026-11-18 SLS SELLAS Life Sciences Group, Inc. Burns John Thomas Officer SELL $19.18 3,831 $73,471 558,893
2026-11-20 22:28 2026-11-19 LPCN Lipocine Inc. Higuchi John W. Director BUY $1.50 150,000 $225,225 391,365
2026-11-20 22:10 2026-11-19 AEON AEON Biopharma, Inc. Sy Jennifer Officer BUY $0.13 153,846 $19,985 1,655,022
2026-11-20 22:11 2026-11-20 AEON AEON Biopharma, Inc. Wilson Alexander Blair Officer BUY $0.13 135,706 $17,479 2,318,711
2026-11-20 21:58 2026-11-18 RCKT ROCKET PHARMACEUTICALS, INC. Shah Gaurav Officer SELL $2.18 2,216 $4,826 1,051,358
2026-11-20 22:00 2026-11-19 CRMD CorMedix Inc. Blum Susan Officer BUY $4.58 5,000 $22,900 129,315
2026-11-20 22:08 2026-11-19 AEON AEON Biopharma, Inc. Bancroft Robert E. Director, Officer BUY $0.13 152,333 $19,590 3,329,436
2026-11-20 21:50 2026-11-20 ORKA Oruka Therapeutics, Inc. Quinlan Paul T Officer OPT+S $94.89 9,000 $853,986 29,995
2026-11-20 21:54 2026-11-18 RCKT ROCKET PHARMACEUTICALS, INC. Wilson Martin Officer SELL $2.18 677 $1,475 540,336
2026-11-20 21:28 2026-11-18 RYTM RHYTHM PHARMACEUTICALS, INC. Shulman Joseph Officer OPT+S $119.90 45,921 $5,506,153 10,461
2026-11-20 21:33 2026-11-19 INSM INSMED Inc Schaeffer Orlov S Nicole Officer OPT+S $145.26 101,100 $14,685,604 41,895
2026-11-20 21:33 2026-11-18 BBIO BridgeBio Pharma, Inc. Kumar Neil Director, Officer SELL $77.86 54,980 $4,280,759 475,686
2026-11-20 21:15 2026-11-18 BBOT BridgeBio Oncology Therapeutics, Inc. Beltran Pedro Director, Officer SELL $1.84 1,870 $3,443 41,659
2026-11-20 21:05 2026-11-19 ANNX Annexon, Inc. Carson William H. Director BUY $3.58 34,000 $121,720 112,405
2026-11-20 21:05 2026-11-19 DARE Dare Bioscience, Inc. RASTETTER WILLIAM H Director SELL $0.45 859 $382 0
2026-11-20 18:34 2026-11-18 CRMD CorMedix Inc. Lefkowitz Steven W Director BUY $4.53 11,500 $52,095 137,451
2026-11-20 13:41 2026-11-18 NMAD NOMAD POWER SOLUTIONS, INC. Holloway Michael Andrew Director BUY $2.82 15,000 $42,300 55,000
2026-11-20 13:45 2026-11-18 IMMX Immix Biopharma, Inc. Morris Gabriel S Director, Officer BUY $7.06 1,418 $10,011 292,847
2026-11-20 13:45 2026-11-18 IMMX Immix Biopharma, Inc. Rachman Ilya M Director, Officer BUY $7.10 1,408 $10,000 1,143,091
2026-11-20 13:19 2026-11-18 FLNA FILANA THERAPEUTICS, INC. Barry Richard Director, Officer BUY $0.52 44,851 $23,323 1,955,947
2026-11-20 13:22 2026-11-18 FLNA FILANA THERAPEUTICS, INC. Anderson Robert Eugene Jr Director BUY $0.52 19,000 $9,880 27,600
2026-11-19 21:30 2026-11-17 NBP NovaBridge Biosciences Hagler Mark Arnold Officer BUY $0.37 230,000 $85,882 460,000
2026-11-19 21:02 2026-11-17 FLNA FILANA THERAPEUTICS, INC. Barry Richard Director, Officer BUY $0.48 132,926 $63,804 1,911,096
2026-11-20 02:51 2026-11-19 AVIR Atea Pharmaceuticals, Inc. Polsky Bruce Director SELL $4.03 8,750 $35,298 149,830
2026-11-20 02:51 2026-11-17 AVIR Atea Pharmaceuticals, Inc. Lucidi Bruno Director OPT+S $3.96 29,360 $116,409 187,990
2026-11-20 02:03 2026-11-18 CRVO CervoMed Inc. ALAM JOHN J Director, Officer, 10% owner BUY $1.53 100,000 $152,620 1,584,078
2026-11-19 23:40 2026-11-19 KURA Kura Oncology, Inc. Powl Brian T. Officer SELL $7.27 448 $3,257 112,817
2026-11-19 23:41 2026-11-19 UTHR UNITED THERAPEUTICS Corp MAHON PAUL A Officer OPT+S $565.09 8,300 $4,690,229 45,172
2026-11-19 23:50 2026-11-17 NKTR NEKTAR THERAPEUTICS Zalevsky Jonathan Officer SELL $35.85 192 $6,883 9,378
2026-11-19 23:50 2026-11-17 NKTR NEKTAR THERAPEUTICS ROBIN HOWARD W Director, Officer SELL $35.85 429 $15,380 54,198
2026-11-19 23:28 2026-11-17 TNGX Tango Therapeutics, Inc. Ketchum John B Director SELL $24.08 3,333 $80,259 21,604
2026-11-19 22:59 2026-11-17 FBIO Fortress Biotech, Inc. ROSENWALD LINDSAY A MD Director, Officer, 10% owner BUY $1.85 136,723 $252,582 4,723,564
2026-11-19 23:04 2026-11-18 BMRN BIOMARIN PHARMACEUTICAL INC Friberg Gregory R Officer SELL $58.81 5,147 $302,711 42,585
2026-11-19 22:54 2026-11-17 FBIO Fortress Biotech, Inc. Jin David Officer BUY $1.84 47,605 $87,812 1,700,366
2026-11-19 22:07 2026-11-17 ELVN Enliven Therapeutics, Inc. Collins Helen Louise Officer OPT+S $46.84 5,000 $234,203 25,000
2026-11-19 21:40 2026-11-17 ACRV Acrivon Therapeutics, Inc. Gamelin Erick Officer SELL $1.45 416 $603 52,176
2026-11-19 21:41 2026-11-18 UTHR UNITED THERAPEUTICS Corp ROTHBLATT MARTINE A Director, Officer OPT+S $578.83 5,410 $3,131,476 324,443
2026-11-19 21:41 2026-11-17 ACRV Acrivon Therapeutics, Inc. Miller Mary Officer SELL $1.45 193 $280 81,009
2026-11-19 21:42 2026-11-17 AVLN Avalyn Pharma Inc. Lazarus Howard Officer OPT+S $27.90 13,300 $371,027 0
2026-11-19 21:43 2026-11-17 ACRV Acrivon Therapeutics, Inc. Peterson Katharine Officer SELL $1.45 107 $155 17,926
2026-11-19 21:52 2026-11-18 NMAD NOMAD POWER SOLUTIONS, INC. Travaglini John Francis Director BUY $2.85 5,000 $14,270 5,000
2026-11-19 21:35 2026-11-19 ZOMDF Zomedica Corp. POWERS JOHNNY D Director BUY $0.08 175,000 $14,525 4,600,000
2026-11-19 21:38 2026-11-17 ACRV Acrivon Therapeutics, Inc. Blume-Jensen Peter Director, Officer SELL $1.45 1,780 $2,581 385,355
2026-11-19 21:39 2026-11-17 ACRV Acrivon Therapeutics, Inc. Devroe Eric Officer SELL $1.45 628 $911 145,721
2026-11-19 21:10 2026-11-17 KROS Keros Therapeutics, Inc. Prener Anne Director SELL $10.83 575 $6,230 12,637
2026-11-19 21:10 2026-11-17 KROS Keros Therapeutics, Inc. Newton Charles W. Director SELL $10.85 551 $5,981 11,563
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Pharmaceutical Preparations

Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.